Humacyte Inc
NASDAQ:HUMA
Humacyte Inc
NASDAQ:HUMA
Price:
0.7784
USD
-5.42%
Market Closed
Market Cap:
$150.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Humacyte Inc
NASDAQ:HUMA
|
US |
|
Americold Realty Trust
NYSE:COLD
|
US |
|
P
|
Polymac Thermoformers Ltd
BSE:537573
|
IN |
|
M
|
MoneyGram International Inc
F:9M1N
|
US |
|
COSCO SHIPPING Development Co Ltd
SSE:601866
|
CN |
|
D
|
DPC Dash Ltd
HKEX:1405
|
CN |
|
Z
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
|
CN |
Balance Sheet
Balance Sheet Decomposition
Humacyte Inc
Humacyte Inc
Balance Sheet Decomposition is not available for
Humacyte Inc
Humacyte Inc
Balance Sheet
Humacyte Inc
Humacyte Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
94
|
40
|
218
|
150
|
80
|
45
|
|
| Cash Equivalents |
94
|
40
|
218
|
150
|
80
|
45
|
|
| Short-Term Investments |
0
|
0
|
8
|
2
|
0
|
0
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
4
|
2
|
3
|
3
|
|
| Total Current Assets |
95
|
41
|
229
|
154
|
83
|
48
|
|
| PP&E Net |
74
|
65
|
57
|
50
|
45
|
39
|
|
| PP&E Gross |
74
|
65
|
57
|
50
|
45
|
39
|
|
| Accumulated Depreciation |
8
|
14
|
20
|
26
|
31
|
36
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
51
|
|
| Total Assets |
169
N/A
|
107
-37%
|
287
+169%
|
204
-29%
|
128
-37%
|
138
+8%
|
|
| Liabilities | |||||||
| Accounts Payable |
3
|
2
|
2
|
2
|
6
|
4
|
|
| Accrued Liabilities |
6
|
5
|
7
|
7
|
9
|
11
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
4
|
2
|
11
|
3
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
3
|
1
|
|
| Total Current Liabilities |
11
|
11
|
11
|
20
|
18
|
20
|
|
| Long-Term Debt |
25
|
24
|
49
|
39
|
55
|
77
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
105
|
29
|
41
|
94
|
|
| Total Liabilities |
37
N/A
|
36
-1%
|
164
+357%
|
87
-47%
|
115
+31%
|
191
+66%
|
|
| Equity | |||||||
| Common Stock |
421
|
421
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
322
|
388
|
415
|
427
|
537
|
686
|
|
| Additional Paid In Capital |
33
|
38
|
537
|
544
|
551
|
633
|
|
| Total Equity |
132
N/A
|
71
-47%
|
122
+73%
|
117
-4%
|
14
-88%
|
53
N/A
|
|
| Total Liabilities & Equity |
169
N/A
|
107
-37%
|
287
+169%
|
204
-29%
|
128
-37%
|
138
+8%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
103
|
103
|
103
|
103
|
104
|
130
|
|
Switch to:
Switch to:
See Also
Discover More
